Development of the Diaphragmatic Paralysis Questionnaire: a simple tool for patient relevant outcome.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 25 06 2020
revised: 02 09 2020
accepted: 04 10 2020
pubmed: 23 11 2020
medline: 22 7 2021
entrez: 22 11 2020
Statut: ppublish

Résumé

Measurement tools of health-related quality of life (HRQL) that are specific for the underlying disorder are inevitably needed to assess HRQL changes following specific treatment strategies. The aim of the current study was to develop a questionnaire assessing HRQL in patients with unilateral diaphragmatic paresis. Firstly, topics of health impairments covering physical, psychological, social and functional aspects were predefined by a physician expert panel to ensure face validity. Secondly, all predefined topics were rated by a patient group with unilateral diaphragmatic paresis (untreated: n = 11; postoperative: n = 9) using a 5-point Likert scale ranging from 'not relevant at all' (-2) to 'absolutely relevant' (+2) to guarantee content validity. Thirdly, only relevant topics (0 to +2) were used for item development, while non-relevant items (<0) were not subject for item development. In total, 20 patients rated a total of 43 topics covering a broad spectrum of health impairment. 21 were considered as relevant for item development. Items are answered on a 5-point Likert scale ranging from 'completely untrue' (-2) to 'always true' (+2). The Diaphragmatic Paralysis Questionnaire (DPQ) Summary Score ranges from 0 (worst HRQL) to 100 (best HRQL). Finally, the German DPQ was professionally translated and transculturally adapted into English, Italian, Dutch, French, Greek and Spanish, using translation/back-translation procedures. The DPQ is the first diseases-specific HRQL measure developed for patients with diaphragmatic paresis. In addition, the DPQ is available in 7 languages free of charge for non-profit purposes. German clinical trials register: DRKS00017056.

Identifiants

pubmed: 33221909
pii: 5998377
doi: 10.1093/icvts/ivaa258
pmc: PMC8906767
doi:

Banques de données

DRKS
['DRKS00017056']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

244-249

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Chest. 1995 Mar;107(3):798-804
pubmed: 7874956
Thorax. 1992 Feb;47(2):76-83
pubmed: 1549827
Semin Respir Crit Care Med. 2009 Jun;30(3):315-20
pubmed: 19452391
Int J Chron Obstruct Pulmon Dis. 2007;2(3):355-9
pubmed: 18229574
Arch Bronconeumol. 2006 Nov;42(11):588-93
pubmed: 17125694
Thorax. 1976 Aug;31(4):438-42
pubmed: 968801
Am J Med. 1962 Mar;32:404-16
pubmed: 14492287
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
N Engl J Med. 1996 Mar 28;334(13):835-40
pubmed: 8596551
Eur Respir J. 2019 Sep 28;54(3):
pubmed: 31467119
Ann Thorac Surg. 1990 Feb;49(2):248-51; discussion 252
pubmed: 2306146
Lung. 2017 Apr;195(2):173-177
pubmed: 28138789
Ann Thorac Surg. 2006 May;81(5):1853-7; discussion 1857
pubmed: 16631685
Annu Rev Public Health. 1994;15:535-59
pubmed: 8054098
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1452-6
pubmed: 20080267
Eur J Med Res. 2009 Dec 7;14 Suppl 4:147-50
pubmed: 20156746
Pneumologie. 2016 Jul;70(7):454-61
pubmed: 27411076
J Cardiothorac Surg. 2010 Nov 15;5:111
pubmed: 21078140
J Cardiovasc Surg (Torino). 2008 Apr;49(2):289-95
pubmed: 18431352
Respir Physiol Neurobiol. 2017 Dec;246:39-46
pubmed: 28790008
Eur J Cardiothorac Surg. 2002 Feb;21(2):294-7
pubmed: 11825738
BMJ Case Rep. 2017 Mar 1;2017:
pubmed: 28249882
Prim Care Respir J. 2012 Sep;21(3):329-36
pubmed: 22885563
JAMA. 2017 Jun 6;317(21):2177-2186
pubmed: 28528348

Auteurs

Nils Jurriaan Kosse (NJ)

Cologne Merheim Hospital, Department of Thoracic Surgery, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Wolfram Windisch (W)

Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Aris Koryllos (A)

Cologne Merheim Hospital, Department of Thoracic Surgery, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Alberto Lopez-Pastorini (A)

Cologne Merheim Hospital, Department of Thoracic Surgery, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Denis Piras (D)

Sankt Marienhospital Birkesdorf, Department of Surgery, Düren, Germany.

Hans-Willi Schroiff (HW)

RWTH Business School, Marketing Department, Rheinische-Westfälische Technische Hochschule, Aachen, Germany.

Stephan Eric Straßmann (SE)

Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Erich Stoelben (E)

Cologne Merheim Hospital, Department of Thoracic Surgery, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Sarah Bettina Schwarz (SB)

Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH